mRNA Technology - Search News

FDA refuses review of mRNA flu vaccine

FDA won’t consider a new mRNA vaccine for flu, despite the technology’s life-saving promise

The U.S. Food and Drug Administration is refusing to consider a new mRNA flu vaccine made by Moderna, the company revealed in a statement on Tuesday.

· 18h · on MSN

FDA refuses to review Moderna’s mRNA flu vaccine application

· 3h

Moderna says FDA refuses its application for new mRNA flu vaccine

· 16h

F.D.A. Refuses to Review Moderna Flu Vaccine

The vaccine maker Moderna said on Tuesday that the Food and Drug Administration had notified the company that the agency would not review its mRNA flu vaccine, the latest sign of federal health policy...

· 12h

Moderna shares fall as FDA declines to review new flu vaccine

· 1d

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

· 1d

FDA Refuses to Consider Approving Use of Moderna’s New Flu Vaccine

The FDA sent Moderna a “refusal-to-file” letter earlier this month, saying the company’s study testing the vaccine wasn’t sufficient, and the agency wouldn’t take up the company’s request for approval...

· 22h

In rare move, FDA rejects Moderna’s filing for mRNA flu shot

· 1d

FDA refuses to review Moderna’s mRNA flu vaccine

MedPage Today on MSN

FDA refuses application for new mRNA flu vaccine, Moderna says

News is latest sign of the agency's heightened scrutiny of vaccines

FDA refuses to consider application for new mRNA flu vaccine, Moderna says

The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The news is the latest sign of the FDA’s heightened scrutiny of vaccines under Health Secretary Robert F.